Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases ...

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

Over 80% of these fatalities result from heart attacks and strokes. December is notorious for being the biggest month for ...

Researchers from Mass General Brigham evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the ...

Stroke is a medical emergency and the leading cause of disability in the United States. There are treatments to reduce the harm from stroke, but they can only be done if the stroke victim comes to the ...